Answers are grounded in this paper and cite their sources.
Astragalus polysaccharides (APS) is one of the core active components of Astragalus membranaceus, a traditional Chinese medicine. APS has several pharmacological effects. These include bidirectional immunomodulation, antitumor effects, and anti-inflammatory effects. APS mechanisms show multi-target, multi-pathway, and multi-link features. Traditional reductionist methods cannot easily explain its regulatory patterns at the systems level.Network pharmacology offers a systematic framework for APS mechanism research. It relies on static databases. It cannot capture the dynamic evolution of immune responses.In recent years, artificial intelligence (AI) has made breakthroughs in biomedicine. AlphaFold is one example. AI offers methodological support for inferring unknown targets from known targets.This review summarizes APS immunomodulatory mechanisms and current network pharmacology applications. It also analyzes the limits of existing methods. A three-stage research framework is then proposed. In this framework, known APS immune targets act as prior anchors. AI builds dynamic immune network models. Potential novel targets are predicted. The goal is to provide new insights for systematic elucidation of APS immune mechanisms.
No takes yet. Share an insight, caveat, or question.
Yuan Feng (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: